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INTRODUCTION
Many people with metabolic syndrome have a low-grade
inflammation that may place them at risk for the develop-
ment of cardiovascular disease. In view of its emerging epi-
demic nature and impact, the early identification of those at
high risk of developing metabolic syndrome would help pre-
vent associated cardiovascular complications. Several epidemi-
ological studies have already noted a relationship between
some components of metabolic syndrome and leukocytes
(1-4). Moreover, leukocyte count has been positively associ-
ated with elevated cardiovascular mortality, mainly due to
coronary heart disease and ischemic stroke (5-9), and it has
been considered to be a marker of inflammation associated
with the initiation and development of atherosclerosis. If
the leukocyte count is an independent risk factor of metabol-
ic syndrome, then it is important to consider the role of the
constituent cell types involved. However, few systemic eval-
uations have investigated the relation between metabolic
syndrome and differential leukocyte counts (10-13).
In this study, we investigated the relationship between
total and differential leukocyte counts and the frequencies
of diabetes, hypertension, dyslipidemia, obesity, and metabol-
ic syndrome, after adjusting for clinical and biochemical
factors.
MATERIALS AND METHODS
Subjects
The medical records of the 15,654 subjects (age, median
46, range 14-90 yr; 8,380 men and 7,274 women) who vis-
ited our Center for Health Promotion for a medical check-
up between January 2002 and December 2003 were inves-
tigated. Since routine medical checks are not covered by the
Korean medical insurance system, we suspect that most of
our study subjects were members of the upper-middle eco-
nomic class. Subjects meeting any of the following criteria
were excluded; a positive test for hepatitis C virus antibody,
a positive test for hepatitis B virus surface antigen, a history
of current antidiabetic/antihypertensive/antilipid medication,
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The Associations of Total and Differential White Blood Cell Counts
with Obesity, Hypertension, Dyslipidemia and Glucose Intolerance in
a Korean Population
Although many studies have reported an association between total white blood cell
count and metabolic syndrome, relatively few reports are available on the associa-
tion between differential white blood cell counts and metabolic syndrome. The medi-
cal records of 15,654 subjects (age, median 46, range 14-90 yr; 8,380 men and
7,274 women) who visited the Center for Health Promotion were investigated. It was
found that as total white blood cell (WBC) and differential WBC counts increased
the frequencies of diabetes, hypertension, obesity, dyslipidemia, and metabolic syn-
drome also increased. Moreover, these significant relationships persisted after adjust-
ing for age, gender, smoking, alcohol intake, educational background, and house-
hold income. The odds ratios (95% CI) for metabolic syndrome was 2.64 (2.30-
3.04) in the highest quartile of total WBC count, with corresponding figures of 2.14
(1.88-2.44) for neutrophils, 2.32 (2.03-2.64) for lymphocytes, 1.56 (1.37-1.78) for
monocytes, 1.36 (1.20-1.54) for basophils, and 1.82 (1.59-2.08) for eosinophils
versus the lowest quartiles of the appropriate total and differential counts, respec-
tively, after adjusting for the variables mentioned above. These independent asso-
ciations were also observed by subgroup analyses according to the smoking sta-
tus. Our data suggest that even within normal ranges, total WBC count and the
differential WBC counts are associated with the presence of metabolic syndrome.
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Accepted : 21 August 2007or an abnormal white blood cell (WBC) count (<3,800 or
>10,000/ L). Subjects were classified into tertiles with respect
to total and differential leukocyte counts. Diabetes was defin-
ed as a fasting plasma glucose ≥7.0 mM/L; hypertension as a
systolic blood pressure ≥140 mmHg and/or a diastolic blood
pressure ≥90 mmHg; dyslipidemia as a serum LDL-choles-
terol low density lipoprotein-cholesterol-C (LDL-C) ≥4.2
mM/L and/or triglyceride ≥2.46 mM/L and/or HDL-choles-
terol high density lipoprotein-cholesterol-C (HDL-C) <1.16
mM/L; obesity as a body mass index ≥25 kg/m2 (14, 15).
The presence of metabolic syndrome was determined using
the definition provided by the Third Report of the National
Cholesterol Education Program Expert Panel on the Detec-
tion Evaluation, and Treatment of High Blood Cholesterol
in Adults (16), as:- three or more of the following abnormal-
ities: body mass index (BMI) ≥25 kg/m2; triglyceride ≥1.7
mM/L; HDL-C <1.04 mM/L; fasting plasma glucose (FPG)
≥6.1 mM/L; systolic blood pressure (SBP) ≥130 mmHg,
and diastolic blood pressure (DBP) ≥85 mmHg. However,
obesity according to the Expert Panel guidelines was not used
as a criterion; instead, BMI was used, because waist circum-
ference measurement was not available. The inclusion of BMI
as a criterion is in line with the definition of metabolic syn-
drome recommended by the Japan Society for the Study of
Obesity (17). This study was approved by the Internal Review
Board (IRB) of the Samsung Medical Center.
Assay methods 
Height and weight were measured with subjects wearing
light clothing but no shoes in the morning; blood pressure
was measured using a mercury sphygmomanometer on the
right arm with subjects in a sitting position after a 5-min
rest. BMI was calculated as weight in kilograms divided by
height in meters squared. Information on lifestyle factors
including alcohol consumption, cigarette smoking, house-
hold income, and educational background were obtained by
trained nurses. Questions about alcohol intake included items
about alcohol consumption frequency per week, and the type
of alcoholic beverage; weekly alcohol intake was calculated
and converted to daily alcohol consumption. Subjects were
classified as non-drinkers or current drinkers when they con-
sumed on average <180 or 181 to <360 g of alcohol/week,
respectively. Heavy alcohol drinking was defined as ≥360
g/week of alcohol. Blood samples were obtained in the morn-
ing after an overnight fast. Plasma glucose was measured in
duplicate by the hexokinase method using an autoanalyzer
(Hitachi, Tokyo, Japan), which had an interassay coefficient
of variation of 1.6%. Standard liver testing, total cholesterol,
HDL-C, LDL-C, triglycerides, and uric acid were measured
using an autoanalyzer (Hitachi, Tokyo, Japan), as were WBC
counts (Sysmex, Kobe, Japan). Plasma fibrinogen was assess-
ed using Clauss method (reagent kit from Dade Behring,
Newark, NJ, U.S.A.). Hepatitis B virus surface antigen
(HBsAg) and Hepatitis C virus antibody (anti-HCV) were
measured using commercially available immunoradiometric
assay kits (both from Riakey, Goyang, Korea). 
Statistics 
Data are expressed as means±SD. Analysis of variance
(ANOVA) or  2 tests were used to compare variables between
tertile groups. Logistic regression analysis was used to obtain
the odds ratios for diabetes, impaired fasting glucose, hyper-
tension, dyslipidemia, obesity, and metabolic syndrome after
adjusting for age, gender, smoking, alcohol intake, education-
al background, and household income. Statistical analyses
were performed using SPSS/PC
+ (SPSS, Inc., Chicago, IL,
U.S.A.), and differences were considered statistically signifi-
cant at a plevel of <0.05.
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Data are means±SD or %. *not significant; 
� p<0.05 by the 
2 test. All
other significances were at the p<0.01 by the 
2 test or ANOVA. Heavy
alcohol drinking was defined as ≥360 grams of alcohol/week. The ranges
of the total leukocyte counts tertiles were 3,800-5,290, 5,291-6,460, and
6,461-10,000/ L, respectively. 
BP, blood pressure; FPG, fasting plasma glucose; AST, serum aspar-
tate aminotransferase; ALT, serum alanine aminotransferase; GGT, serum
gamma glutamyl transferase; BUN, blood urea nitrogen.
1st tertile
(3,800-
5,290/ L)
N=5,226
2nd tertile
(5,291-
6,460/ L)
N=5,223
3rd tertile
(6,461-
10,000/ L)
N=5,205
Age (yr) 46.7±10.3 46.6±10.6 46.0±10.4
Male sex (%) 40.6 54.1 65.9
Body mass index (kg/m
2) 23.0±2.8 23.7±2.9 24.2±3.1
Systolic BP (mmHg) 114.9±16.7 117.8±17.3 119.6±17.5
Diastolic BP (mmHg) 70.5±11.3 72.5±11.6 73.9±11.9
FPG (mM/L) 5.11±0.70 5.18±0.84 5.21±1.01
LDL-cholesterol (mM/L) 3.36±0.87 3.43±0.87 3.51±0.87
Triglyceride (mM/L) 1.16±0.71 1.40±0.86 1.63±1.02
HDL-cholesterol (mM/L) 1.44±0.35 1.36±0.33 1.30±0.32
Hemoglobin (g/dL)* 14.2±1.6 14.4±1.5 14.3±1.7
Total leukocyte (/ L) 4,624±412 5,843±339 7,585±885
AST (IU/mL) 21.7±9.6 23.1±13.9 23.8±10.6
ALT (IU/mL) 22.8±18.6 26.7±22.2 30.2±21.9
GGT (IU/mL) 26.8±33.8 34.5±41.5 40.5±42.4
BUN (mg/dL)* 12.1±3.1 12.2±3.1 12.2±3.2
Creatinine (mg/dL)* 0.9±0.2 0.9±0.2 0.9±0.2
BUN/creatinine* 13.4±3.7 13.5±3.7 13.4±3.8
Fibrinogen (g/dL) 2.74±0.54 2.83±0.56 2.94±0.65
Uric acid ( M/L) 273.6±77.3 297.4±77.3 315.2±83.3
Past smoking/current  20.6/13.5 24.5/21.7 20.5/37.8
smoking (%)
Alcohol drinking (%) 55.0 62.1 68.3
Heavy alcohol drinking (%) 3.7 5.1 6.6
College or university 
graduation (%)* 51.4 53.1 52.0
Household income  45.6 43.9 43.2
≥40,000 US dollars/yr
�(%)
Table 1. Clinical characteristics of study subjects according to
total leukocyte counts RESULTS
The clinical characteristics of study subjects according to
total leukocyte count are presented in Table 1. Univariate
analyses showed that the following increased with increas-
ing total leukocyte count; BMI, systolic and diastolic BP, fast-
ing plasma glucose, lipid profile, serum aspartate amino-
transferase (AST), serum alanine aminotransferase (ALT),
gamma-glutamyl transferase (GGT), fibrinogen, uric acid,
and a male gender, heavy alcohol drinking, and current smok-
ing. Age, HDL-C, and household income decreased with
increasing total leukocyte counts. 
Logistic regression analyses showed that the frequencies of
obesity, hypertension, diabetes, and dyslipidemia increased
as total leukocyte, neutrophil, and lymphocyte counts increas-
ed after adjusting for age, gender, smoking, alcohol intake,
educational background, and household income (Table 2).
Total and differential leukocyte counts increased with increase
in numbers of components of metabolic syndrome (Table 3).
Because smoking was identified as a major determinant of
leukocyte count, we performed a subgroup analyses to fur-
ther examine this feature. It was found that in all three smok-
ing subgroups total and differential leukocyte counts were
independently associated with the presence of metabolic syn-
drome, with the exception of basophil counts in past-smok-
ers and current smokers (Table 4). 
Men had higher total leukocyte counts and higher alcohol
consumption and smoking frequencies than women. We per-
formed logistic regression analyses to determine the odd ratios
of the presence of metabolic syndrome with respect to total and
differential leukocyte counts in both genders (Table 5). In both
men and women, all differential and total leukocyte counts
were significantly associated with the presence of metabolic
syndrome after adjusting for the above mentioned variables. 
To determine which component of the differential leuko-
cyte count was more strongly related to metabolic syndrome,
we performed logistic regression analyses using the individ-
ual differential leukocyte counts as covariates. The calculat-
ed odds ratios (95% CI) of metabolic syndrome (for highest
versus lowest count quartiles) were: 1.76 (1.53-2.02) for neu-
trophils, 1.96 (1.71-2.25) for lymphocytes, and 1.59 (1.38-
1.83) for eosinophils. However, monocyte and basophil show-
ed no significant difference. 
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Obesity Hypertension Diabetes Dyslipidemia
Total WBC vs. 1st tertile
p for trend <0.001 <0.001 <0.001 <0.001
2nd tertile 1.45 (1.33-1.59) 1.24 (1.10-1.40)
� 1.24 (0.92-1.68)
� 1.35 (1.24-1.46)
3rd tertile 1.70 (1.56-1.86) 1.59 (1.41-1.80) 1.81 (1.37-2.41) 1.77 (1.63-1.93)
Neutrophil vs. 1st tertile
p for trend <0.001 <0.001 <0.001 <0.001
2nd tertile 1.30 (1.20-1.42) 1.25 (1.11-1.41) 1.62 (1.21-2.17)
� 1.25 (1.15-1.35)
3rd tertile 1.32 (1.21-1.44) 1.78 (1.32-1.67) 1.90 (1.43-2.53) 1.37 (1.26-1.49)
Lymphocyte vs. 1st tertile
p for trend < 0.001 <0.001 <0.05 <0.001
2nd tertile 1.36 (1.25-1.49) 1.12 (1.08-1.37)
� 0.99 (0.75-1.32)
� 1.520 (1.40-1.65)
3rd tertile 1.94 (1.78-2.12) 1.51 (1.34-1.70) 1.31 (1.01-1.71)* 2.04 (1.88-2.22)
Monocyte vs. 1st tertile
p for trend <0.001 <0.05 NS <0.001
2nd tertile 1.20 (1.10-1.31) 1.11 (0.98-1.25)
� 1.06 (0.80-1.41)
� 1.09 (1.00-1.18)*
3rd tertile 1.36 (1.25-1.49) 1.18 (1.05-1.34)
� 1.18 (0.89-1.56)
� 1.25 (1.15-1.36)
Basophil vs. 1st tertile
p for trend NS NS <0.05 <0.001
2nd tertile 1.07 (0.98-1.17)
� 1.12 (1.00-1.26)
� 1.39 (1.05-1.84)* 1.15 (1.06-1.25)
�
3rd tertile 1.08 (0.99-1.18)
� 1.11 (1.00-1.25)
� 1.46 (1.11-1.92)
� 1.21 (1.11-1.31)
Eosinophil vs. 1st tertile
p for trend <0.001 NS NS <0.001
2nd tertile 1.44 (1.32-1.57)  0.96 (0.86-1.08)
� 0.93 (0.72-1.23)
� 1.32 (1.21-1.43)
3rd tertile 1.55 (1.42-1.70)  0.87 (0.77-0.98)
� 1.04 (0.80-1.37)
� 1.36 (1.25-1.48)
Table 2. Odds ratios for obesity, hypertension, diabetes, and dyslipidemia versus total and differential leukocyte counts
NS, not significant. *<0.05; 
� <0.01; 
� not significant. All other odds ratios were p<0.001. All odds ratios were adjusted for age, gender, smoking, alcohol
intake, educational background, and household income. Definitions; obesity as body mass index ≥25 kg/m
2; hypertension as an SBP ≥140 mmHg and/or
a DBP ≥90 mmHg; dyslipidemia as an LDL-C ≥4.1 mM/L and/or a triglyceride of ≥2.46 mM/L and/or a HDL-C of <1.16 mM/L. Total leukocyte counts
by tertile were the same as shown in Table 1, and were:- 1,070-2,806, 2,807-3,676, and 3,677-8,199 for neutrophils, 146-1,748, 1,749-2,224, and 2,225-
5,727 for lymphocytes, 0-315, 316-410, and 411-1,714 for monocytes, 0-22, 23-34, and 35-397 for basophils and 0-88, 89-176, and 177-2,671/ L for eosinophils,
respectively.
WBC, white blood cell, SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL-C, low density lipoprotein-cholesterol; HDL-C, high density
liprotein-cholesterol. DISCUSSION
Our analysis demonstrates that leukocyte count, even within
its normal range, is closely related to the presence of the com-
ponents of metabolic syndrome after adjusting for age, gen-
der, smoking, alcohol consumption, educational background,
and income. Our results are consistent with previous find-
ings concerning the significance of the relationship between
total leukocyte count and metabolic syndrome (18-20), and
with its components, namely, obesity, high blood pressure,
and high serum triglyceride (21, 22). 
Although several studies previously revealed these associ-
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Total Never-smoker Past smoker Current smoker
Total WBC vs. 1st tertile
p for trend <0.001 <0.001 <0.001 <0.001
2nd tertile 1.83 (1.59-2.11) 1.73 (1.37-2.19) 1.67 (1.31-2.12) 1.67 (1.34-2.09)
3rd tertile 2.45 (2.13-2.81) 2.55 (2.04-3.19) 2.10 (1.66-2.66) 2.12 (1.71-2.64)
Neutrophil vs. 1st tertile
p for trend <0.001 <0.001 <0.001 <0.001
2nd tertile 1.54 (1.35-1.76) 1.34 (1.07-1.67)* 1.64 (1.29-2.08) 1.54 (1.24-1.91)
3rd tertile 1.90 (1.67-2.16) 2.02 (1.64-2.49) 1.86 (1.48-2.35) 1.81 (1.46-2.25)
Lymphocyte vs. 1st tertile
p for trend <0.001 <0.001 <0.001 <0.001
2nd tertile 1.40 (1.22-1.61) 1.31 (1.04-1.66)* 1.30 (1.03-1.65)* 1.77 (1.42-2.21)
3rd tertile 2.17 (1.90-2.46) 2.36 (1.91-2.91) 1.78 (1.42-2.24) 2.15 (1.72-2.67)
Monocyte vs. 1st tertile
p for trend <0.001 <0.001 <0.05 <0.001
2nd tertile 1.24 (1.09-1.42)
� 1.26 (1.01-1.57)* 1.33 (1.05-1.67)*  1.49 (1.20-1.86)
3rd tertile 1.46 (1.28-1.66) 1.56 (1.26-1.93) 1.40 (1.12-1.77)
� 1.69 (1.36-2.09)
Basophil vs. 1st tertile
p for trend <0.001 <0.001 NS NS
2nd tertile 1.26 (1.11-1.43) 1.33 (1.07-1.65)
� 1.20 (0.96-1.51)
� 1.13 (0.92-1.40)
�
3rd tertile 1.30 (1.15-1.47) 1.57 (1.28-1.93) 1.15 (0.92-1.44)
� 1.12 (0.91-1.38)
�
Eosinophil vs. 1st tertile
p for trend <0.001 <0.001 <0.001 <0.01
2nd tertile 1.52 (1.32-1.74) 1.58 (1.25-1.99) 1.51 (1.19-1.91)
� 1.29 (1.04-1.60)*
3rd tertile 1.74 (1.52-1.99) 1.93 (1.54-2.41) 1.69 (1.33-2.13) 1.49 (1.21-1.85)
Table 4. Odds ratios for metabolic syndrome according to total and differential leukocyte counts
*<0.05; 
� <0.01; 
� not significant. All other odds ratios were p<0.001. All odds ratios were adjusted for age, gender, smoking, alcohol intake, educational
background, and household income. Metabolic syndrome was defined as the presence of 3 or more of the following abnormalities: BMI ≥25 kg/m
2;
triglyceride ≥1.7 mM/L; HDL-C <1.04 mM/L; FPG ≥6.1 mM/L; and SBP ≥130 mmHg and/or DBP ≥85 mmHg. In all subjects, the ranges of the total
and differential leukocyte counts in the tertiles were as shown in Table 2. In never-smokers these were 3,800-5,050, 5,051-6,150, and 6,151-10,000
for total leukocytes, 1,096-2,707, 2,708-3,536, and 3,537-8,199 for neutrophils, 146-1,711, 1,712-2,121, and 2,122-5,057 for lymphocytes, 7-294, 295-
379, and 380-1,714 for monocytes, 0-21, 22-32, and 33-397 for basophils, and 0-71, 72-139, and 140-2,268 for eosinophils, respectively. In pastsmok-
ers these were 3,800-5,323, 5,324-6,400, and 6,401-10,000 for total leukocytes, 1,070-2,807, 2,808-3,604, and 3,605-7,571 for neutrophils, 756-1,979,
1,798-2,236, and 2,237-5,727 for lymphocytes, 0-22, 23-34, and 35-180 for basophils, and 0-99, 100-190, and 191-2,671 for eosinophils, respective-
ly. In current smokers, these were 3,800-5,900, 5,901-7,200, and 7,201-10,000 for total leukocytes, 1,200-3,079, 3,080-4,063, and 4,064-7,950 for neu-
trophils, 541-1,971, 1,972-2,445, and 2,446-4,726 for lymphocytes, 0-25, 26-38, and 39-246 for basophils, and 0-129, 130-240, and 241-2,200 for
eosinophils, respectively. WBC, white blood cell.
Total WBC Neutrophil Lymphocyte Monocyte Basophil Eosinophil
Numbers of components 
of metabolic syndrome
0 (n=6,357) 5,765±17 3,263±14 1,946±7 366±1 30.5±0.2 162±2
1 (n=4,533) 6,024±19 3,394±16 2,056±8 375±2 31.1±0.3 170±2
2 (n=2,851) 6,258±25 3,483±20 2,173±10 391±2 31.8±0.3 182±3
3 (n=1,455) 6,421±35 3,583±28 2,220±14 396±3 32.5±0.5 189±4
4 (n=430) 6,627±63 3,711±51 2,270±25 398±6 33.9±0.9 214±8
5 (n=28) 6,450±246 3,589±198 2,199±99 398±22 36.2±3.4 228±30
Table 3. Association of total and differential leukocyte counts with numbers of components of metabolic syndrome controlling after
age and gender
Data are means±SEM. All p for  trend were  <0.001 by ANCOVA. Ages were adjusted as 46.43 yr old. WBC, white blood cell.ations, these studies have usually involved a relatively small
numbers of subjects, and the exclusion criteria adopted were
insufficient. Unlike other studies, subjects positive for hep-
atitis C virus antibody and/or hepatitis B virus surface anti-
gen, which are prevalent in Korea, were excluded, as were
subjects with a recent history of antidiabetic, antihyperten-
sive, or antilipid medication because of the possibility that
these drugs could have affected leukocyte counts. 
The mechanism of the relationship between leukocyte
counts and cardiovascular disease has not been clarified. As
cytokines are potent inducers of leukocyte differentiation,
we speculated that an activated cytokine system might lead
to elevated leukocyte levels. Furthermore, activated differ-
entiated leukocytes can produce more cytokines. There is a
possibility that hormones such as cortisol or insulin, which
are known to be increased in metabolic syndrome, then stim-
ulate leukocyte propagation (23-25). Some data are available
on the association between differential leukocyte counts and
coronary heart disease. Prentice et al. were the first to ana-
lyze differential leukocyte counts, and found that elevated
neutrophil and eosinophil counts were both related to the
development of coronary heart disease, and further suggested
a similar relationship for monocyte count (26), and this rela-
tionship between coronary heart disease and monocyte counts
was confirmed by Olivares et al. (11). Caerphilly and Speed-
well found significant increases of neutrophil and eosinophil
count in men who developed ischemic heart disease during
follow-up (27), and the Atherosclerosis Risk in Communi-
ties study found that those in the highest quartiles for mono-
cyte and granulocyte counts had a higher rate of cardiovas-
cular disease mortality than those in the lowest quartiles (9). 
Tanigawa et al. reported that total leukocyte and total lym-
phocyte counts, and more specifically, memory cell counts
are elevated in middle-aged men with clustered features of
metabolic syndrome (28). To the best of our knowledge, this
is the first report to find significant associations between dif-
ferential and total leukocyte counts and metabolic syndrome
after adjusting for age, gender, smoking, alcohol intake, edu-
cational background, and household income. The reason for
the differences between our results and those of Tanigawa et
al. are uncertain. The first possibility concerns sample size
differences, as the larger sample size used in the present study,
compared to that of Tanigawa et al. (15,654 vs. 439), would
have enabled us to detect smaller differences. The second
possibility concerns the compositions of study subjects. Our
study included both men and women in the range of age 14-
90 yr, whereas Tanigawa et al. included only middle-aged men.
The present study has several limitations. This is a cross-
sectional study, thus we only observed the association between
leukocyte count and metabolic syndrome and could not deter-
mine the causal relationship. Although our study was rela-
tively large in scale, the possibilities of using differential leuko-
cyte counts as risk markers for metabolic syndrome require
prospective study. Another limitation of the present study is
that insulin resistance, a key component of metabolic syn-
drome, was not measured, and thus no direct relationship
between insulin sensitivity and leukocyte counts was demon-
strated. Moreover, we used BMI alone as a parameter of obesi-
ty, and waist circumference or some other parameter of obesi-
ty that more accurately reflects insulin resistance or athero-
genicity would have been more preferable because obesity is
a major determinant of leukocyte count. In addition, because
this was not a population-based study, our results are limit-
ed in terms of their meaningfulness in the Korean popula-
tion. In view of the fact that subjects with a college or uni-
versity graduation constituted 52.2% of the study popula-
tion and 44.2% had a relatively high income (household
income ≥40,000 US dollars/yr), it is apparent that our study
subjects represented the upper socioeconomic Korean class. 
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*<0.05; 
� <0.01; 
� not significant. All other odds ratios were p<0.001. All
odds ratios were adjusted for age, smoking, alcohol intake, educational
background, and household income. Metabolic syndrome was defined
as in the legend of Table 4. In men, the ranges in each tertile were 3,800-
5,580, 5,581-6,800, and 6,801-10,000 for total leukocytes, 1,070-2,922,
2,923-3,810, and 3,811-7,950 for neutrophils, 388-1,864, 1,865-2,330, and
2,331-5,727 for lymphocytes, 0-346, 347-448, and 449-1,376 for mono-
cytes, 0-22, 23-36, and 37-246 for basophils, and 0-112, 113-217, and
218-2,671 for eosinophils, respectively. In women, these were 3,800-
5,000, 5,001-6,100, and 6,101-10,000 for total leukocytes, 1,096-2,680,
2,681-3,514, and 3,515-8,199 for neutrophils, 146-1,701, 1,702-2,109,
and 2,110-5,057 for lymphocytes, 7-289, 290-369, and 370-1,714 for
monocytes, 0-21, 22-32, and 33-397 for basophils, and 0-68, 69-130,
and 131-2,132 for eosinophils, respectively. WBC, white blood cell. 
Men Women
Total WBC vs. 1st tertile
p for trend <0.001 <0.001
2nd tertile 1.87 (1.61-2.16) 1.31 (0.97-1.77)
�
3rd tertile 2.38 (2.05-2.77) 2.25 (1.70-2.96)
Neutrophil vs. 1st tertile
p for trend <0.001 <0.001
2nd tertile 1.52 (1.32-1.76) 1.29 (0.97-1.73)
�
3rd tertile 1.83 (1.59-2.11) 2.04 (1.55-2.67)
Lymphocyte vs. 1st tertile
p for trend <0.001 <0.001
2nd tertile 1.31 (1.13-1.51) 1.29 (0.95-1.78)
�
3rd tertile 1.97 (1.71-2.27) 2.23 (1.68-2.97)
Monocyte vs. 1st tertile
p for trend <0.001 <0.01
2nd tertile 1.28 (1.11-1.47)
� 1.21 (0.91-1.61)
�
3rd tertile 1.44 (1.25-1.66) 1.61 (1.23-2.11)
�
Basophil vs. 1st tertile
p for trend <0.01 <0.01
2nd tertile 1.18 (1.02-1.36)* 1.49 (1.12-1.99)
�
3rd tertile 1.25 (1.09-1.44)
� 1.59 (1.21-2.10)
�
Eosinophil vs. 1st tertile
p for trend <0.001 <0.001
2nd tertile 1.38 (1.19-1.58) 1.60 (1.19-2.16)
�
3rd tertile 1.55 (1.35-1.78) 2.12 (1.59-2.82)
Table 5. Odds ratios for metabolic syndrome according to an
increase in the total and differential leukocyte counts in men
vs. womenIn conclusion, the results of the present study suggest that
even within normal ranges, total leukocyte count and all dif-
ferential leukocyte count examined are independently associ-
ated with the presence of metabolic syndrome. Future prospec-
tive studies are required to determine which differential leuko-
cyte counts are most associated with metabolic syndrome
development.
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